NCT05397262View on ClinicalTrials.gov

Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia

NARecruitingINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

December 31, 2098

Study Completion Date

December 31, 2099

Conditions

Bladder Cancer

Interventions

OTHER

Hyperthermia

Deep Regional Hyperthermia (RHT) 1-2/week up to 10 sessions a type of cancer treatment in which body tissue is exposed to high temperatures (up to 113°F).

RADIATION

Radiotherapy

50,4 Gy (28 x 1,8 Gy) plus Boost: If R0: 5,4 Gy; If R1/2: 9 Gy

DRUG

Chemotherapy 5-Fluorouracil

600 mg/m\^2 civ 120h; d 1-5, 29-33

DRUG

Chemotherapy Cisplatin

20 mg/m\^2; d1-5, 29-33

Trial Locations (1)

91054

RECRUITING

Dept. of Radiation Therapy, University Hospital Erlangen, Erlangen

All Listed Sponsors

lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT05397262 - Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia | Biotech Hunter | Biotech Hunter